Literature DB >> 15289912

[Acute airway obstruction in acquired hemophilia A].

J B Weise1, H Plendl, F Gieseler, S Preuss, S Maune.   

Abstract

We report the case of a 67 year old patient suffering from acute airway obstruction caused by hemorrhage localized to the tongue, mouth cavity and hypopharynx, with no evidence of bleeding in his history. The patient presented initially with a globus feeling of the neck, dysphagia and a sore throat. CT scan revealed a swelling of the lingual and sublingual areas and the pharyngeal wall. Next day, there was an immediate life-threatening event caused by progressive bleeding with airway obstruction and an inability to intubate requiring coniotomy. The etiology of the hemorrhage was confirmed by finding a depletion of factor VIII and the presence of auto-antibody directed against this factor. Based on this case report and a review of the literature, we discuss the diagnosis and treatment of acquired hemophilia.

Entities:  

Mesh:

Year:  2005        PMID: 15289912     DOI: 10.1007/s00106-004-1116-y

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  12 in total

Review 1.  Treatment of haemophilia in the United Kingdom 1981-1996.

Authors:  C R Rizza; R J Spooner; P L Giangrande
Journal:  Haemophilia       Date:  2001-07       Impact factor: 4.287

2.  Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease.

Authors:  T Matsumoto; M Shima; K Fukuda; K Nogami; J C Giddings; T Murakami; I Tanaka; A Yoshioka
Journal:  Thromb Res       Date:  2001-12-15       Impact factor: 3.944

3.  Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus.

Authors:  S Schulman; P Langevitz; A Livneh; U Mortinowitz; U Seligsohn; D Varon
Journal:  Thromb Haemost       Date:  1996-09       Impact factor: 5.249

4.  The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.

Authors:  B Verbruggen; I Novakova; H Wessels; J Boezeman; M van den Berg; E Mauser-Bunschoten
Journal:  Thromb Haemost       Date:  1995-02       Impact factor: 5.249

5.  Rituximab in the treatment of acquired factor VIII inhibitors.

Authors:  Adrian Wiestner; Hearn J Cho; Adam S Asch; Mary Ann Michelis; Jack A Zeller; Ellinor I B Peerschke; Babette B Weksler; Geraldine P Schechter
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

6.  Acquired factor VIII inhibitor associated with prostatic cancer: successful treatment with steroid and immunosuppressive therapy.

Authors:  F Moccia; E Tognoni; P Boccaccio
Journal:  Ann Ital Med Int       Date:  2000 Apr-Jun

7.  The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study.

Authors:  C R Hay; C Negrier; C A Ludlam
Journal:  Thromb Haemost       Date:  1997-12       Impact factor: 5.249

8.  A population based, unselected, consecutive cohort of patients with acquired haemophilia A.

Authors:  Peter Collins; Nicola Macartney; Richard Davies; Steven Lees; John Giddings; Ray Majer
Journal:  Br J Haematol       Date:  2004-01       Impact factor: 6.998

9.  Airway obstruction in hemophilia (factor VIII deficiency): a 28-year institutional review.

Authors:  C J Bogdan; M Strauss; O D Ratnoff
Journal:  Laryngoscope       Date:  1994-07       Impact factor: 3.325

10.  Detection of two different anti-factor VIII/von Willebrand factor antibodies of the IgA class in a hemophilic patient with a polyclonal factor VIII inhibitor of the IgG class.

Authors:  E Carmona; J A Aznar; J I Jorquera; M J Villanueva; J M Sánchez-Cuenca
Journal:  Thromb Res       Date:  1991-07-01       Impact factor: 3.944

View more
  1 in total

1.  Acute airway compromise and coagulopathy: a rare presentation of acquired haemophilia A.

Authors:  William Byron Howden; Jonathan Kam; Nicholas Leith; Shashinder Singh
Journal:  BMJ Case Rep       Date:  2020-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.